Atlas Trials

Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery

Clinical trial NCT03424239 · COMPLETED

Trial details

NCT number
NCT03424239
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Bariatric Surgery Candidate
Start date
2018-08-01
Primary completion
2020-01-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.